Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

Objective To identify predictors of immune-related adverse events (IRAEs) in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). Assess associations between outcomes and the development of IRAEs.Methods Retrospective analysis of patients with NSCLC trea...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: M. Serino, C. Freitas, M. Martins, P. Ferreira, C. Cardoso, F. Veiga, V. Santos, D. Araújo, H. Novais-Bastos, A. Magalhães, H. Queiroga, G. Fernandes, V. Hespanhol
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis Group 2024-07-01
Edice:Pulmonology
Témata:
NSCLC
immune checkpoint Inhibitors
Immune-related adverse events
outcomes
On-line přístup:https://www.tandfonline.com/doi/10.1016/j.pulmoe.2022.03.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky